These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32324452)

  • 1. Role of nurses in addressing modifiable risk factors for early Alzheimer's disease and mild cognitive impairment.
    Hope K
    Br J Nurs; 2020 Apr; 29(8):460-469. PubMed ID: 32324452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Strategies to prevent age-related cognitive decline].
    Meyer AM; Podolski N; Pickert L; Polidori MC
    Dtsch Med Wochenschr; 2020 Feb; 145(3):146-150. PubMed ID: 32018286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
    Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
    Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline.
    Daviglus ML; Bell CC; Berrettini W; Bowen PE; Connolly ES; Cox NJ; Dunbar-Jacob JM; Granieri EC; Hunt G; McGarry K; Patel D; Potosky AL; Sanders-Bush E; Silberberg D; Trevisan M
    NIH Consens State Sci Statements; 2010 Apr; 27(4):1-30. PubMed ID: 20445638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
    Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective.
    Baumgart M; Snyder HM; Carrillo MC; Fazio S; Kim H; Johns H
    Alzheimers Dement; 2015 Jun; 11(6):718-26. PubMed ID: 26045020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use it or lose it! Cognitive activity as a protec-tive factor for cognitive decline associated with Alzheimer's disease.
    Mistridis P; Mata J; Neuner-Jehle S; Annoni JM; Biedermann A; Bopp-Kistler I; Brand D; Brioschi Guevara A; Decrey-Wick H; Démonet JF; Hemmeter U; Kressig RW; Martin B; Rampa L; Savaskan E; Stuck A; Tschopp P; Zekry D; Monsch A
    Swiss Med Wkly; 2017; 147():w14407. PubMed ID: 28322422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alexithymia in people with subjective cognitive decline, mild cognitive impairment, and mild Alzheimer's disease.
    Yuruyen M; Akcan FE; Batun GC; Gultekin G; Toprak M; Yavuzer H; Emul M
    Aging Clin Exp Res; 2017 Dec; 29(6):1105-1111. PubMed ID: 28110464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive benefits of natural nutrition and lifestyle counseling against Alzheimer's disease onset.
    Polidori MC
    J Alzheimers Dis; 2014; 42 Suppl 4():S475-82. PubMed ID: 25238764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual Cognitive Assessment for Older Adults: Update for Nurses.
    Wiese LK; Williams CL
    J Community Health Nurs; 2015; 32(4):187-98. PubMed ID: 26529104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are neuropsychiatric symptoms modifiable risk factors for cognitive decline in Alzheimer's disease and vascular dementia?
    Savulich G; O'Brien JT; Sahakian BJ
    Br J Psychiatry; 2020 Jan; 216(1):1-3. PubMed ID: 31036096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green Tea Intake and Risks for Dementia, Alzheimer's Disease, Mild Cognitive Impairment, and Cognitive Impairment: A Systematic Review.
    Kakutani S; Watanabe H; Murayama N
    Nutrients; 2019 May; 11(5):. PubMed ID: 31137655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifestyle Patterns as a Modifiable Risk Factor for Late-life Cognitive Decline: A Narrative Review Regarding Dementia Prevention.
    Wajman JR; Mansur LL; Yassuda MS
    Curr Aging Sci; 2018; 11(2):90-99. PubMed ID: 30280679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A methodological critique of the National Institute of Aging and Alzheimer's Association Guidelines for Alzheimer's disease, dementia, and mild cognitive impairments.
    Garrett MD; Valle R
    Dementia (London); 2016 Mar; 15(2):239-54. PubMed ID: 24662500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression-an underrecognized target for prevention of dementia in Alzheimer's disease.
    Dafsari FS; Jessen F
    Transl Psychiatry; 2020 May; 10(1):160. PubMed ID: 32433512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer's Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials.
    Kishi T; Matsunaga S; Oya K; Ikuta T; Iwata N
    Int J Neuropsychopharmacol; 2015 Jun; 18(12):. PubMed ID: 26091818
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.